Guselkumab for treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and drug-survival for up to 148 weeks.

导出 LinkOut

翻译打印收藏纠错

作者： Marco,Galluzzo ^[1] ; Lorenzo,Marcelli ^[2] ; Laura,Vellucci ^[1] ; Claudia,Paganini ^[2] ; Virginia,Maffei ^[1] ; Lorenzo,Tofani ^[2] ; Alfredo,Belcastro ^[1] ; Luca,Bianchi ^[2] ; Marina,Talamonti ^[1]

作者单位： Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy. ^[1] Dermatology Unit, Fondazione Policlinico "Tor Vergata", Rome, Italy. ^[2] School of Medicine and Surgery, University of Rome "Tor Vergata", Rome, Italy. ^[3]

关键词 PASI Psoriasis biologic therapy guselkumab

主题词人类(Humans);抗体, 单克隆(Antibodies, Monoclonal);横断面研究(Cross-Sectional Studies);疾病严重程度指数(Severity of Illness Index);双盲法(Double-Blind Method);银屑病(Psoriasis);治疗结果(Treatment Outcome)

DOI 10.1080/14712598.2023.2194485

PMID 36971507

发布时间 2023-05-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交